Multivariate methods in pharmaceutical applications

被引:175
作者
Gabrielsson, J
Lindberg, NO
Lundstedt, T
机构
[1] Melacure Therapeut AB, SE-75643 Uppsala, Sweden
[2] Umea Univ, Res Grp Chemometr, SE-90187 Umea, Sweden
[3] Pharmacia AB, SE-25109 Helsingborg, Sweden
[4] Uppsala Univ, BMC, Dept Organ Pharmaceut Chem, SE-75123 Uppsala, Sweden
关键词
pharmaceutical applications; multivariate methods; design;
D O I
10.1002/cem.697
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
This review covers material published within the field of pharmacy in the last five years. Articles concerning experimental design, optimization and applications of multivariate techniques have been published, from factorial designs to multivariate data analysis, and the combination of the two in multivariate design. The number of publications on this topic testifies to the good results obtained in the studies. Much of the published material highlights the usefulness of experimental design, with many articles dealing with optimization, where much effort is spent on getting useful results. Examples of multivariate data analysis are comparatively few, but these methods are gaining in use. The employment of multivariate techniques in different applications has been reviewed. The examples in this review represent just a few of the possible applications with different aims within pharmaceutical applications. A number of companies are using experimental design as a standard tool in preformulation and in combination with response surface modeling. The properties of e.g. a tablet can be optimized to fulfill a well-specified aim such as a specific release profile, hardness, disintegration time etc, However, none of the companies apply multivariate methods in all steps of the drug development process. As this is still very much a growing field, it is only a question of time before experimental design, optimization and multivariate data analysis are implemented throughout the entire formulation process, from performulation to multivariate process control. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:141 / 160
页数:20
相关论文
共 104 条
[1]   Critical dissolution tests of oral systems based on statistically designed experiments.: II.: In vitro optimization of screened variables on ER-coated spheres for the establishment of an in vitro in vivo correlation [J].
Abuzarur-Aloul, R ;
Gjellan, K ;
Sjölund, M ;
Graffner, C .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (03) :203-212
[2]   Critical dissolution tests of oral systems based on statistically designed experiments.: III.: In vitro in vivo correlation for multiple-unit capsules of paracetamol based on PLS modeling [J].
Abuzarur-Aloul, R ;
Gjellan, K ;
Sjölund, M ;
Graffner, C .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (04) :371-383
[3]   Critical dissolution tests of oral systems based on statistically designed experiments .1. Screening of critical fluids and in vitro in vivo modelling of extended release coated spheres [J].
AbuzarurAloul, R ;
Gjellan, K ;
Sjolund, M ;
Lofqvist, M ;
Graffner, C .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (08) :749-760
[4]   Formulation and evaluation of release and swelling mechanism of a water-in-oil emulsion using factorial design [J].
Bjerregaard, S ;
Söderberg, I ;
Vermehren, C ;
Frokjaer, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 193 (01) :1-11
[5]   SOME FACTORS INFLUENCING THE FORMATION AND IN-VITRO DRUG-RELEASE FROM MATRIX PELLETS PREPARED BY EXTRUSION SPHERONIZATION [J].
BLANQUE, D ;
STERNAGEL, H ;
PODCZECK, F ;
NEWTON, JM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 119 (02) :203-211
[6]   Optimization of hydrophilic matrix tablets using a D-optimal design [J].
Bodea, A ;
Leucuta, SE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 153 (02) :247-255
[7]   Optimization of propranolol hydrochloride sustained-release pellets using Box-Behnken design and desirability function [J].
Bodea, A ;
Leucuta, SE .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (02) :145-155
[8]   Optimization of propranolol hydrochloride sustained release pellets using a factorial design [J].
Bodea, A ;
Leucuta, SE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (01) :49-57
[9]  
BOLHUIS G, 1995, PHARM TECHNOL EUR, V8, P42
[10]   Optimization of a granulation procedure for a hydrophilic matrix tablet using experimental design [J].
Bouckaert, S ;
Massart, DL ;
Massart, B ;
Remon, JP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (04) :321-327